<DOC>
	<DOCNO>NCT01005888</DOCNO>
	<brief_summary>The study objective determine safety efficacy C1INH-nf prevention acute HAE attack .</brief_summary>
	<brief_title>C1 Esterase Inhibitor ( C1INH-nf ) Prevention Acute Hereditary Angioedema ( HAE ) Attacks</brief_title>
	<detailed_description>Subjects give diary card instruct document HAE attack daily basis . Subjects evaluate symptom previous 24 hour , note severity duration swell 5 location ( abdominal , genitourinary , facial , respiratory [ include laryngeal ] , and/or extremity ) . The study design also allow administration open-label C1INH-nf ( 1,000 U C1INH-nf administer IV [ repeat 60 minute , necessary ] treatment laryngeal angioedema deem necessary investigator ; 1,000 U C1INH-nf administer IV [ single dose ] prior emergency surgical procedure ) . A total 26 subject enrol study . One subject receive open-label C1INH-nf withdrew prior randomization . Another subject randomize withdraw prior receive study drug . Twenty-four ( 24 ) subject randomize treat blinded study drug . In total , 25 subject receive least 1 dose study drug analyze safety ; 25 subject expose C1INH-nf 23 subject expose placebo .</detailed_description>
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Angioedemas , Hereditary</mesh_term>
	<mesh_term>Complement C1s</mesh_term>
	<mesh_term>Complement C1 Inhibitor Protein</mesh_term>
	<mesh_term>Complement C1 Inactivator Proteins</mesh_term>
	<criteria>Documented HAE Normal C1q level Relatively frequent angioedema attack ( least 2 per month average ) Low C1q level Bcell malignancy Presence antiC1INH autoantibody History allergic reaction C1INH blood product Narcotic addiction Current participation investigational drug study within past 30 day Participation C1 esterase inhibitor trial , receive blood blood product past 90 day Pregnancy lactation Any clinically significant medical condition , renal failure , opinion investigator would interfere subject 's ability participate study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Hereditary angioedema</keyword>
	<keyword>HAE</keyword>
	<keyword>C1 esterase inhibitor ( human )</keyword>
	<keyword>C1INH-nf</keyword>
</DOC>